Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Completed Phase 3 Trials for Pneumococcal Infection / Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT05158140Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)